Company Overview of Cerexa, Inc.
Cerexa, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective therapies for the treatment of antibiotic-resistant infections. It provides Ceftaroline AcetateCeftaroline, an injectable cephalosporin that is used for the treatment of bacterial infections caused by gram-positive and gram-negative pathogens. The company was founded in 2005 and is based in Alameda, California. Cerexa Inc.operates as a subsidiary of Allergan plc.
2100 Franklin Street
Oakland, CA 94612
Founded in 2005
Key Executives for Cerexa, Inc.
Similar Private Companies By Industry
|Wynden Pharmaceuticals LLC||United States|
|US Biologic, Inc.||United States|
|Met-Rx USA, Inc.||United States|
|Pharma Marketing Ltd.||United States|
|Kowa Pharmaceuticals America, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cerexa, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.